Iterative Health is a Cambridge, MA-based healthtech company that combines AI and deep learning with clinical trial expertise to accelerate research in gastroenterology, hepatology, and other therapeutic areas. Its proprietary AI technologies — including computer vision for endoscopic scoring and AI-driven patient recruitment — are deployed across a global network of 100+ research sites to improve clinical trial execution and expand patient access to novel therapeutics.
“Iterative Health ($77M) — part of healthcare AI and digital health absorbing substantial institutional funding.”
“Iterative Health…runs a network of clinical trial sites and uses AI to identify patients, manage studies, and improve enrollment and execution…raised a $77M Series C.”